MAP3K5 and fatty liver disease: A recently published study revealed that the hepatocyte-specific knockout of ASK1 in HFD-fed mice leads to a higher degree of hepatic steatosis, inflammation, and fibrosis, along with slightly impaired glucose clearance [64].